Skip to the page

Data / Form D filings / Headlands Holdco, LLC

Headlands Holdco, LLC: Form D filing

Headlands Holdco, LLC, a biotechnology company in Boston, MA, filed a Form D with the SEC in 2026. The latest, on July 15, 2026, reports $3.1 million sold of a $3.1 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
100 FEDERAL STREET 35TH FLOOR, Boston, MA, 02110
Phone
(617) 227-1050
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2145480

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 15, 2026New notice$3,100,000$3,100,0001Jun 26, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joshua Matthew NelsonExecutive Officer, DirectorManager and President of the Issuer
Megan PreinerDirectorManager of the Issuer
Peter McLellandDirectorManager of the Issuer
Kyle BurtnettDirectorManager of the Issuer

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Headlands Holdco, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.